Skip to main content
Filing year 2024

ACTION TO CURE KIDNEY CANCER

New York, New York·EIN 20-0441399·NTEE H12 · Medical Research·501(c)(3)
Total revenue
$10k
Total assets
$98k
Total expenses
$2k
Reported officers
2

Reported officers (all unpaid)

No paid executives reported in 2024. ACTION TO CURE KIDNEY CANCER reported 2 unpaid officers and board members on its 990-EZ.

President
Treasurer
Sector benchmark

What Medical Research executives earn in New York

ACTION TO CURE KIDNEY CANCER reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable medical research organization in New York earns a median of $165,152.

25th percentile
$62k
Median
$165,152
75th percentile
$300k
90th percentile
$611k

These are medical research sector-wide figures, not this organization's reported pay. Based on 101 organizations across 101 filings (2022 – 2024).

See full Medical Research pay data for New York →
FAQ

Common questions about ACTION TO CURE KIDNEY CANCER

What are ACTION TO CURE KIDNEY CANCER's revenue and expenses?

In 2024, ACTION TO CURE KIDNEY CANCER reported $10k in total revenue and $2k in total expenses on its IRS Form 990.

Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.